Open access peer-reviewed chapter

False-Positive Serologic Reactions for Syphilis

Written By

Nikolay Potekaev, Olga Zhukova and Irina Khamaganova

Submitted: 19 June 2022 Reviewed: 07 July 2022 Published: 24 August 2022

DOI: 10.5772/intechopen.106370

Chapter metrics overview

165 Chapter Downloads

View Full Metrics

Abstract

The epidemiologic situation of syphilitic infection warrants attention to diagnostic methods. Nontreponemal tests (rapid plasma regain, Venereal Disease Research Laboratory) are less reliable, as there are certain situations when false-positive reactions for syphilis antibodies may appear. Variable examinations were performed and proved that it was necessary to assess the titer of antibodies, as well as confirmation of the diagnosis by treponemal tests (fluorescent treponemal antibody, treponema pallidum hemagglutination assay, enzyme immunoassay, Western blot), were obligatory. In recent decades, new methods were elaborated (e.g., BioPlex total screen, tests with β2-GPI-dependent anticardiolipin antibody, the ARCHITECT syphilis treponema pallidum chemiluminescent immunoassay, the Elecsys immunoassay (Roche Diagnostics)). We present the review of publications on syphilis serologic diagnostics and present our own research. We did not find any mention of a false-positive test in atopic dermatitis and present a case of false-positive reactions for syphilis in such patients.

Keywords

  • syphilis
  • serologic diagnostic
  • nontreponemal tests
  • treponemal tests
  • false-positive serologic reactions

1. Introduction

The incidence of syphilis has been increasing from the end of twentieth century—early 2000s [1, 2], warranting attention to diagnostic methods. Now we have serious problems in serologic diagnostic of different clinical forms of syphilis, including those of atypical duration, cardiovascular syphilis, neurosyphilis, congenital syphilis, latent forms, etc. Nontreponemal tests (rapid plasma regain, Venereal Disease Research Laboratory) are less reliable as there are certain situations when false-positive reactions for syphilis antibodies may appear. Variable examinations were performed and proved that it was necessary to assess the titer of antibodies, as well as confirmation of the diagnosis by treponemal tests (fluorescent treponemal antibody, treponema pallidum hemagglutination assay, enzyme immunoassay, Western blot), were obligatory. In recent decades, new methods were elaborated (e.g., BioPlex total screen, tests with β2-GPI-dependent anticardiolipin antibody, the ARCHITECT syphilis treponema pallidum chemiluminescent immunoassay, the Elecsys immunoassay (Roche Diagnostics)) [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15] to exclude false-positive and false-negative reactions. Syphilis as the “great imitator” may be presented by a variety of clinical signs and symptoms of infection that can be easily confused with other diseases [16, 17, 18]. But in spite of miscellaneous investigations, complexities in the diagnosis of syphilis continue to challenge clinicians [19, 20, 21, 22, 23, 24]. For instance, discordant maternal reverse-sequence serology is still a problem in diagnosis of congenital syphilis [25, 26]. We analyzed the papers presented in PUB MED. By the end of December 2021, the search query “False-positive reactions for syphilis” gave 743 publications. We included the papers published in English from January 2010 till the end of December 2021. We excluded the papers publicized earlier than in 2010, written in other languages than English, and those which had nothing to do with our demand “False-positive tests for syphilis”. So, we analyzed 88 publications and presented our own research. We did not find any mention of false-positive tests in atopic dermatitis and present a case of false-positive reactions for syphilis in such patients.

Advertisement

2. Clinical situations with false-positive syphilis reactions

A substantial problem is presented now by discordant serologic reactions for syphilis in different clinical situations [27, 28, 29, 30, 31]. Huh et al. [32] pointed to the growth of false-positive reactions in syphilis screening assays and proved that the reverse algorithm using Automated Mediace Treponema pallidum latex agglutination (TPLA) as a screening serologic test is preferred over rapid plasma reagin (RPR) assays [3233]. Furthermore, the biological false-positive Venereal Disease Research Laboratory (VDRL)—cerebrospinal fluid test is often used in cases when patients are examined without a previous serological diagnosis of syphilis [20]. Palamar et al. retrospectively explored the serologic blood sample and microbiological culture media analysis results of all cornea donors. False-positive serologic results among cornea donors were high [34], which underlines the importance of the improvement of serologic diagnostic in this field. Last year, different clinical situations confirmed the actual need for further serologic investigations [24, 35, 36, 37].

Dunseth et al. underlined the necessity of differentiation between analytical false-positive results of lues tests from clinical false-positive results. A positive syphilis IgG screen with negative RPR and T. pallidum particle agglutination assay (TP-PA) confirmatory testing could be considered an analytical false-positive. A positive syphilis IgG with positive TP-PA and negative RPR might be an analytical false-positive due to cross-reacting antibodies or analytical true-positive result in late/latent syphilis or past/treated syphilis with persistent anti-syphilis IgG. Nontreponemal tests may show false-positive screens due to a variety of reasons [38]. Ishihara et al. presented a retrospective study of patients tested for syphilis in a tertiary academic hospital. Among 94,462 subjects, 588 patients had false-positive tests (0.62%). Such cases were noted in patients aged over 60 years, with a history of malignancy and autoimmune diseases [36]. But the false-positive tests for syphilis were noted in children as well [37]. Over all 90% of biologically false-positive reactions are low titer (≤1:4), but (1%) are high-titer (≥1:32) [24]. Such reactions are categorized as either acute (occurring for less than 6 months) or chronic [19, 28]. Acute false-positive reactions are noted in febrile illnesses, immunizations, and pregnancy [29, 30, 31, 38, 39, 40]. For example, Nwosu et al. examined 2156 women, VDRL was positive in 15 cases (0.70%). Confirmatory T. pallidum hemagglutination assay was positive in 4 of the 15 cases, giving an overall prevalence of 0.19% and a false-positive rate of 73.3%. There was no significant difference in the prevalence of syphilis in relation to maternal age and parity (P > 0.05) [41].

As for chronic false-positive reactions, they can be noted in such clinical cases as hepatitis C virus (HCV) infection, intravenous drug use, malignancy, older age, malaria, Chagas disease, tuberculosis, leprosy, and connective tissue diseases [28]. Besides, false-positive test is a characteristic clinical sign in patients with systemic lupus erythematosus [42, 43]. It is proved now that false-positive results of serologic reactions for syphilis may be caused by HCV [44]. Some investigations showed that different types of cryoglobulinemia might be accompanied by acute or chronic false-positive reactions [45].

Further investigation demonstrated that racial and environmental factors, as well as immuno-chromatographic dual syphilis rapid testing may affect [46], and that can be used in clinical practice.

Augenbraun et al. concluded that HCV infection was associated with certain mechanisms changing the immune function including alterations in serological reactions results. He underlined as well that women with HCV were more likely to have biological false-positive syphilis tests than women without HCV [47].

Furthermore, Bright et al. noted that false-positive reactions might be marked in patients treated with pooled human immunoglobulin G infusions [48].

In 2014, Liu et al. named diseases that had not been previously reported to be associated with the classical biological false-positive reaction, such as false-labor, megaloblastic anemias, aplastic anemias, redundant prepuce, congenital malformation of heart, and salpingitis [49].

Nowadays the significance of sera with isolated reactive treponemal chemiluminescence immunoassay (IRTCIA) results is being discussed. It is known that as a rule, women have this phenotype more commonly than men. Bopage et al. presented the results of the examination 19/63 (30.1%) subjects with the IRTCIA phenotype, which were positive in the line immunoblot assay (LIA). It was marked that women were substantially less likely to have definitive results (positive or negative) than men (p = 0.015). And women who were pregnant less likely than nonpregnant women to have a negative LIA result (OR 0.57; p = 0.03). Record review of 22 different women with IRTCIA reactivity allowed to reveal that 2/22 (9.1%) had HIV and previous syphilis infection, 15/22 (68.2%) were pregnant, and 3 (13.6%) had autoimmune disease [50].

McGready et al. emphasized that the potential impact of false-positive tests should be considered in HIV- positives [51]. And vice versa, false-negative lues tests are noted in HIV- positives subjects [52].

Cantor et al. analyzed a 2004 systematic review of studies of syphilis screening effectiveness, test accuracy, and screening harms in nonpregnant women and adolescents. It was proved that screening HIV-positive men or men who have sex with men (MSM) for syphilis every 3 months is associated with improved syphilis detection [53].

Today there are no doubts that HIV-positive patients [54, 55], MSM, and transgender women are at high risk of acquiring syphilis and HIV infection [56].

The results presented by Kalou et al. indicate that this assay could have a significant impact on the simultaneous screening of HIV and syphilis using a single test device for high-risk populations or pregnant women needing timely care and treatment [57]. Shakya et al. also underlined the importance of simultaneous diagnosis of HIV and syphilis [58].

Grégoire et al. presented the results of the examination of donors who had false-positive tests for HIV, HBV, HCV, or syphilis. Rates of second false-positive results were compared by year of deferral, transmissible disease marker, gender, age, donor status (new or repeat), and testing platform (same or different) both at qualification for re-entry and afterward. The risk, when analyzed by multivariate analyses, of a second deferral for a false-positive result, both at qualification and 3 years after reentry, was lower for donors deferred on a different platform; this risk was higher for HIV, HCV and syphilis than for HBV and for new donors if tested on the same platform [59]. The importance of thorough examination of HIV subjects with false-positive reactions for syphilis was marked in other investigations as well [60, 61].

Sandes et al. presented the results of analyses of the positive and false-positive tests of treponemal and nontreponemal tests in blood donors and found out that older donors and donors with lower education levels were associated with a higher risk of positivity for syphilis [62].

Advertisement

3. Modern serologic diagnostic

The World Health Organization recommendations of screening for syphilis in a low prevalence population of blood donors using enzyme-linked immune-sorbent assay (ELISA) may be adopted for usage in transfusion services that have the facility of ELISA [63].

On the other hand, the current screening of deceased organ donors by RPR yields a significant number of false-positive results [64].

And vice versa, in patients with positive Lyme screening and negative confirmatory testing, the performance of lues serology should be considered [29, 65, 66].

Park et al. [67], Hoover and Radolf [68], Dassah et al. emphasized the importance of the improvement of the serologic diagnostic [69]. Overall, nontreponemal tests were less sensitive than treponema-specific tests [70].

Nah et al. investigated the efficacy of traditional and reverse syphilis diagnostic algorithms during general health checkups. In total, 1000 blood specimens were obtained from 908 men and 92 women. As a result, the reverse screening algorithm could detect the subjects with possible latent syphilis who were not detected by the traditional algorithm [71].

Rourk and Litwin investigated the recently FDA cleared BioPlex 2200 syphilis total screen and automated RPR assay for the detection of total (IgG/IgM) treponemal and nontreponemal antibodies in the reverse syphilis algorithm. They concluded that the addition of the detection of treponemal IgM antibodies to the IgG/IgM screen had not significantly affected the sensitivity and specificity compared to the original IgG screen. But the addition of the comparable BioPlex RPR assay to the instrumentation significantly reduced the overall labor of syphilis screening and confirmation [72].

Yen-Lieberman et al. noted that regardless of the method, laboratories should develop approaches to identify analytical false-positive results wherever possible [73].

The syphilis testing may be affected by different racial and environmental factors [46], which is necessary to keep in mind at the estimation of serologic results.

Zhou et al. marked a high correlation between electrochemiluminescence immunoassay analyzer and chemiluminescent magnetic microparticle immunoassay. Both had high sensitivity and specificity [74].

The appearance of β2-GPI-dependent anticardiolipin antibody and its association with blood coagulation have been investigated in subjects with classical biological false-positive syphilis reactions. Subjects with false-positive tests for syphilis appeared to be more prone to blood coagulation disorders than syphilis patients, and these autoantibodies may impact the intrinsic coagulation cascade in cases of false-positive reactions, similar to presumed antiphospholipid antibody syndrome patients [75].

Considering the importance of the diagnosis of syphilis, antibodies to T. pallidum in serum samples should be retested by the improved ELISA method to avoid false-positive results [76]. Different reverse syphilis testing algorithms were proposed [77].

While in screening populations, discrepancies between chemiluminescent microparticle immunoassay and treponema pallidum particle agglutination results are quite prevalent, confirmation by immunoblot assay may be useful [78]. The ARCHITECT syphilis treponema pallidum chemiluminescent immunoassay accurately diagnoses current or past syphilis in pregnancy [79].

The Elecsys immunoassay (Roche Diagnostics) yielded no false-negative results and fewer false-positive results, compared to the other tests [80]. However, Li et al. underlined that the Elecsys® syphilis assay might be confirmed by other treponemal immunoassays [81].

Enders et al. noted that the specificity of the Elecsys syphilis assay in patients with other infections had been 100%; no false-positive samples had been identified [82].

Simčič and Potočnik supported the European Center for Disease Prevention and Control algorithm in the serodiagnosis of syphilis in high-prevalence populations and the use of nontreponemal serology to monitor the response to treatment [83].

Song et al. evaluated diagnostic methods for revealing syphilis in children. False-positive tests for syphilis were higher in the children’s group than in the infant’s group. The high false-positive rate of enzyme-linked immuno-sorbent assay (ELISA) could be caused by hemolysis. The RPR had low sensitivity in suspected syphilis neonates, and the colloidal gold test (SYP) was suitable for emergency treatment. The treponema pallidum particle agglutination test (TPPA) was fit for the diagnosis of syphilis [84].

It is obvious that further investigations are necessary, and different forms of syphilis need a specific complex of serologic reactions.

Advertisement

4. Own research

Since January 2014 till December 2021, we examined nine patients with false-positive serologic tests for syphilis, aged 48—79. They had no medical documentation with any mentioning of syphilis was presented. They denied syphilitic infection in the past. Three patients were diagnosed with breast cancer, three patients were diagnosed with ovarian cancer, two patients were diagnosed with lupus erythematosus, and one patient was diagnosed with liver cancer.

A 79-year-old patient with liver cancer suffered from diabetes mellitus and obesity as well. The patient denied syphilitic infection in anamnesis. No clinical signs of syphilis were revealed. He was examined thoroughly, and four times during examination and before the operation the micro-reaction of precipitation with plasma and in activated serum and inactivated serum was false-positive, treponemal tests (reaction of passive hemagglutination, immunoenzyme analysis for treponema pallidum) were negative.

A 49-year-old patient suffering from chronic cholecystitis, a 50-year-old patient suffering from thyroiditis, 51-year-old patient suffering from diabetes mellitus showed false-positive serologic reactions for syphilis during the examination and before the operation for breast cancer showed false- positive micro-reaction of precipitation with plasma and in activated serum and inactivated serum was revealed in these cases, treponemal tests (reaction of passive hemagglutination, immunoenzyme analysis for treponema pallidum) were negative.

A 48-year-old patient, 50-year-old patient, 51-year-old patient had no concomitant diseases, and only after revealing ovarian cancer false-positive micro-reaction of precipitation with plasma and in activated serum and inactivated serum was revealed in these cases, treponemal tests (reaction of passive hemagglutination, immunoenzyme analysis for treponema pallidum) were negative. Repeated studies did not show any changes in serologic reactions.

A 49- and 60-year-old patients with chronic lupus erythematosus showed false-positive reactions for syphilis since their first diagnosis of lupus erythematosus, accordingly 20 and 37 years ago.

As a result of our search, we proved that different clinical situations (cancer, lupus erythematosus) were accompanied by false-positive tests for syphilis, but we did not find any mention of false-positive test in atopic dermatitis (AD). Meanwhile, the disease is not rare in different countries [85, 86, 87, 88, 89, 90, 91, 92]. Now, we present the case.

Advertisement

5. Case

A 37-year-old man suffered from AD since the age of 3 months. Most part of his childhood he spent in hospitals due to exacerbations of AD. The treatment included pharmacotherapy and physiotherapy treatment. Usually, hospital courses were accompanied by subsequent spa courses. No seasonality was noted. In adulthood, the patient worked as a software developer, but the exacerbations of atopic dermatitis continued to be frequent. For the past 3 years the micro-reaction of precipitation with plasma and in activated serum and inactivated serum was false-positive, no clinical signs of syphilis were revealed, and treponemal tests (reaction of passive hemagglutination, immunoenzyme analysis for treponema pallidum) were negative. Earlier the patient had passed some childhood infections, and acute respiratory viral infections. The patient denied syphilitic infection in anamnesis. And no medical documentation with any mention of syphilis was presented.

The past 2 weeks’ acute inflammation on the skin is noted. The patient suffered from severe itching and insomnia. The face, scalp, neck, trunk, and upper and lower extremities are involved. The skin is dry. The periorbital zone presented moderate swelling and rugosity. The mouth angles are infiltrated (Figure 1). The elbow bands and popliteal spaces are lichenificated (Figure 2). Polymorphous eruptions with infiltrated erythema, excoriations, and superficial erosions with irregular borders were located on the scalp, neck, trunk, and extremities. Dermographism is persistent white.

Figure 1.

Lesions on the face.

Figure 2.

Lesions in popliteal areas.

The results of blood analysis were within normal limits, except the erythrocyte sedimentation rate, which was 43.

The analysis of AIDS and hepatitis was negative.

The micro-reaction of precipitation with plasma and in activated serum and inactivated serum was negative both with capillary and venous blood. The reaction of passive hemagglutination, immunoenzyme analysis for treponema pallidum) were negative.

So, the patient with severe AD had typical false-positive tests for syphilis, when the nontreponemal test was positive and treponemal tests were negative.

Advertisement

6. Conclusion

To summarize, the problem of false-positive tests for syphilis needs a multidisciplinary approach as it may accompany different diseases and the complex diagnostics tests must be upgraded. Chronic inflammation of long duration, immune changes of reactivity may lead to increased production of antibodies to lipids or plasma proteins and false-positive tests for syphilis in a patient with a severe duration of atopic dermatitis.

References

  1. 1. Mattei PL, Beachkofsky TM, Gilson RT, Wisco OJ. Syphilis: A reemerging infection. American Family Physician. 2012;86(5):433-440
  2. 2. Sethi S, Mewara A, Hallur V, Prasad A, Sharma K, Raj A. Rising trends of syphilis in a tertiary care center in North India. Indian Journal of Sex Transmitted Diseases AIDS. 2015;36(2):140-143
  3. 3. Boonchaoy A, Wongchampa P, Hirankarn N, Chaithongwongwatthana S. Performance of chemiluminescent microparticle immunoassay in screening for syphilis in pregnant women from low-prevalence, resource-limited setting. Journal of Medical Association Thailand. 2016;99(2):119-124
  4. 4. Cantor A, Nelson HD, Daeges M, Pappas M. Screening for Syphilis in Nonpregnant Adolescents and Adults: Systematic Review to Update the 2004 U.S. Preventive Services Task Force Recommendation [Internet]. Evidence Syntheses. 2016;2016:136
  5. 5. Dlamini NR, Phili R, Connolly C. Evaluation of rapid syphilis tests in KwaZulu-Natal. Journal of Clinical Laboratory Analysis. 2014;28(1):77-81
  6. 6. Donkers A, Levy HR, Letens-van VA. Syphilis detection using the Siemens ADVIA centaur syphilis treponemal assay. Clinica Chimica Acta. 2014;433:84-87
  7. 7. Li D, Chen Z, Tao C. Comparison of three syphilis algorithms in West China. Clinica Chimica Acta. 2019;488:76-80
  8. 8. Obafemi OA, Wendel KA, Anderson TS, Scott TE, Rowan SE, Travanty EA, et al. Rapid syphilis testing for men who have sex with men in outreach settings: Evaluation of test performance and impact on time to treatment. Sexually Transmitted Diseases. 2019;46(3):191-195. DOI: 10.1097/OLQ.0000000000000932
  9. 9. Park BG, Yoon JG, Rim JH, Lee A, Kim HS. Comparison of six automated Treponema-specific antibody assays. Journal of Clinical Microbiology. 2016;54(1):163-167
  10. 10. Richards J, Matthias J, Baker C, Wilson C, Peterman TA, Brown CP, et al. Evaluation of rapid syphilis testing using the syphilis health check in Florida, 2015-2016. Florida Public Health Review. 2019;16:13
  11. 11. Sarkodie F, Ullum H, Owusu-Dabo E, Owusu-Ofori S, Owusu-Ofori A, Hassall O. A novel strategy for screening blood donors for syphilis at Komfo Anokye teaching hospital, Ghana. Transfusion Medicine. 2016;26(1):63-66
  12. 12. Shimelis T, Tadesse E. The diagnostic performance evaluation of the SD BIOLINE HIV/syphilis duo rapid test in southern Ethiopia: A cross-sectional study. BMJ Open. 2015;5(4):e007371
  13. 13. Xu M, Xie Y, Jiang C, Xiao Y, Kuang X, Zhao F, et al. A novel ELISA using a recombinant outer membrane protein, rTp0663, as the antigen for serological diagnosis of syphilis. International Journal of Infectious Diseases. 2016;43:51-57
  14. 14. Zhiyan L, Meiling W, Ping L, Jinhua D, Zhenlin Y, Zhenru F. Consistency between Treponema pallidum particle agglutination assay and Architect chemiluminescent microparticle immunoassay and characterization of inconsistent samples. Journal of Clinical Laboratory Analysis. 2015;29(4):281-284
  15. 15. Zhuang YH, Liu H, Tang J, Wang YZ, Zheng XH, Gong Y, et al. Screening for syphilis with dual algorithms: Analysis of discordant and concordant serology results in a population with a low prevalence of syphilis. Journal of the European Academy of Dermatology and Venereology. 2019;33(1):178-184
  16. 16. Ngan W, Chiu PK, Chung HY. Primary Sjogren syndrome masquerading as a false-positive venereal disease research laboratory and fluorescent treponemal antibody absorption test in an elderly woman. Journal of the American Geriatrics Society. 2014;62(9):1817-1818. DOI: 10.1111/jgs.13013
  17. 17. Shi H, Luo W, Li W, Shen C, Liu X, Liu F, et al. Serologic false-positive reactions for syphilis in children of allergic purpura. Clinical Chemistry and Laboratory Medicine. 2015;53(9):e223-e225. DOI: 10.1515/cclm-2014-0489
  18. 18. Soreng K, Levy R, Fakile Y. Serologic testing for syphilis: Benefits and challenges of a reverse algorithm. Clinical Microbiology Newsletter. 2014;36(24):195-202. DOI: 10.1016/j.clinmicnews.2014.12.001
  19. 19. Harman LE, Margo CE, Roetzheim RG. Uveitis: The collaborative diagnostic evaluation. American Family Physician. 2014;90(10):711-716
  20. 20. Morshed MG, Singh AE. Recent trends in the serologic diagnosis of syphilis. Clinical and Vaccine Immunology. 2015;22(2):137-147
  21. 21. Patriquin G, LeBlanc J, Heinstein C, Roberts C, Lindsay R, Hatchette TF. Cross-reactivity between Lyme and syphilis screening assays: Lyme disease does not cause false-positive syphilis screens. Diagnostic Microbiology and Infectious Disease. 2016;84(3):184-186
  22. 22. Cantor AG, Pappas M, Daeges M, Nelson HD. Screening for syphilis: Updated evidence report and systematic review for the US preventive services task force. Screening for syphilis: Updated evidence report and systematic review for the US preventive services task force. Journal of the American Medical Association. 2016;315(21):2328-2337. DOI: 10.1001/jama.2016.4114
  23. 23. Negash M, Wondmagegn T, Geremew D. Comparison of RPR and ELISA with TPHA for the diagnosis of syphilis: Implication for updating syphilis point-of-care tests in Ethiopia. Journal of Immunology Research. 2018;2018:2978419
  24. 24. Matthias J, Klingler EJ, Schillinger JA, Keller G, Wilson C, Peterman TA. Frequency and characteristics of biological false-positive test results for syphilis reported in Florida and New York City, USA, 2013 to 2017. Journal of Clinical Microbiology. 2019;57(11):e00898
  25. 25. Patel NU, Oussedik E, Landis ET, Strowd LC. Early congenital syphilis: Recognising symptoms of an increasingly prevalent disease. Journal of Cutaneous Medical Surgery. 2018;22(1):97
  26. 26. Chen MW, Akinboyo IC, Sue PK, Donohue PK, Ghanem KG, Detrick B, et al. Evaluating congenital syphilis in a reverse sequence testing environment. Perinatol. 2019;39(7):956-963
  27. 27. Thorley N, Adebayo M, Smit E, Radcliffe K. The management of isolated positive syphilis enzyme immunoassay results in HIV-negative patients attending a sexual health clinic. International Journal of STD & AIDS. 2016;27(9):798-800
  28. 28. Wang KD, Xu DJ, Su JR. Preferable procedure for the screening of syphilis in clinical laboratories in China. Infectious Diseases (Lond). 2016;48(1):26-31
  29. 29. Eldin C, Jaulhac B, Mediannikov O, Arzouni JP, Raoult D. Values of diagnostic tests for the various species of spirochetes. Médecine et Maladies Infectieuses. 2019;49(2):102-111
  30. 30. Withers K, Bristow C, Nguyen M, Stafylis C, Giang LM, Klausner JD. A field evaluation of a rapid dual immunoassay for human immunodeficiency virus and syphilis antibodies, Hanoi, Vietnam. International Journal of STD AIDS. 2019;30(2):173-180
  31. 31. Caswell RJ, Hathorn E, Manavi K. The significance of isolated reactive treponemal enzyme immunoassay in the diagnosis of early syphilis. Sexually Transmitted Diseases. 2016;43(6):365-368. DOI: 10.1097/OLQ.0000000000000446
  32. 32. Huh HJ, Chung JW, Park SY, Chae SL. Comparison of automated treponemal and nontreponemal test algorithms as first-line syphilis screening assays. Annals of Laboratory Medicine. 2016;36(1):23-27. DOI: 10.3343/alm.2016.36.1.23
  33. 33. Murai R, Yamada K, Yonezawa H, Yanagihara N, Takahashi S. Evaluation of new algorithm using TPLA as an initial syphilis screening test. Journal of Infection and Chemotherapy. 2019;25(1):68-70
  34. 34. Palamar M, Degirmenci C, Sertoz R, Aydemir S, Egrilmez S, Yagci A. Serologic evaluation of cornea donors and microbiologic evaluation of cornea storage Media in an eye Bank from Izmir, Turkey. Experiment in Clinical Transplantation. 2017;15(6):685-688
  35. 35. Zheng S, Lin RJ, Chan YH, Ngan CCL. Biological false-positive venereal disease research laboratory test in cerebrospinal fluid in the diagnosis of neurosyphilis - a case-control study. Journal of the European Academy of Dermatology and Venereology. 2018;32(3):474-481
  36. 36. Ishihara Y, Okamoto K, Shimosaka H, Ono Y, Kanno Y, Ikeda M, et al. Prevalence and clinical characteristics of patients with biologically false-positive reactions with serological syphilis testing in contemporary practice: 10-year experience at a tertiary academic hospital. Sexually Transmitted Infections. 2021;97(6):397-401
  37. 37. Wang W, Fan X, Huang X, Yan J, Luan J. Serologic false-positive reactions for syphilis in children of adenoidal hypertrophy:2 case reports and review of the literature. Acta Clinica Belgica. 2021;76(1):70-74
  38. 38. Dunseth CD, Ford BA, Krasowski MD. Traditional versus reverse syphilis algorithms: A comparison at a large academic medical center. Practical Lab Medicine. 2017;28(8):52-59
  39. 39. Lin JS, Eder ML, Bean S. Screening for syphilis infection in pregnant women: Updated evidence report and systematic review for the US preventive services task force. Journal of the American Medical Association. 2018;320(9):918-925. DOI: 10.1001/jama.2018.7769
  40. 40. De Carolis S, Tabacco S, Rizzo F, Perrone G, Garufi C, Botta A, et al. Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women. Lupus. 2018;27(5):841-846
  41. 41. Nwosu BO, Eleje GU, Obi-Nwosu AL, Ahiarakwem IF, Akujobi CN, Egwuatu CC, et al. Is routine antenatal venereal disease research laboratory test still justified? Nigerian experience. International Journal of Womens Health. 2015;7:41-46
  42. 42. Ahn SS, Jung SM, Yoo J, Lee SW, Song JJ, Park YB. Clinical characteristics of patients with systemic lupus erythematosus showing a false-positive result of syphilis screening. Rheumatology International. 2019;39(11):1859-1866
  43. 43. Dan Gheorghe AC, Hodorogea AS, Georgescu CE, Ciobanu A, Nanea IT, Gheorghe GS. Diagnostic pitfalls in a man with systemic lupus erythematous. European Journal of Case Report and Internal Medicine. 2019;6(11):001256
  44. 44. Salado-Rasmussen K, Knudsen A, Krarup HB, Katzenstein TL, Gerstoft J. Undetectable hepatitis C virus RNA during syphilis infection in two HIV/HCV-co-infected patients. Scandinavian Journal of Infectious Diseases. 2014;46(9):617-623
  45. 45. Mao CH, Shen M. Peripheral neuropathy caused by cryoglobulinaemia with false-positive serological tests of syphilis. Chinese Medical Journal. 2013;126(10):1996
  46. 46. Mbopi-Keou FX, GCM K, Voundi EV, Jenabian MA, Mboumba Bouassa RS, Talla F, et al. Differential influence of race and environment on indeterminate reactivities to non-treponemal and treponemal antigens by immuno-chromatographic dual syphilis rapid test. Pan African Medical Journal. 2019;33:90
  47. 47. Augenbraun M, French A, Glesby M, Sanchez-Keeland L, Young M, Greenblatt R, et al. Hepatitis C virus infection and biological false-positive syphilis tests. Sexually Transmitted Infections. 2010 Apr;86(2):97-98. DOI: 10.1136/sti.2009.040360
  48. 48. Bright PD, Smith L, Usher J, Donati M, Johnston SL, Gompels MM, et al. False interpretation of diagnostic serology tests for patients treated with pooled human immunoglobulin G infusions: A trap for the unwary. Clinical Medicine (London, England). 2015;15(2):125-129. DOI: 10.7861/clinmedicine.15-2-125
  49. 49. Liu F, Liu LL, Guo XJ, Xi Y, Lin LR, Zhang HL, et al. Characterization of the classical biological false-positive reaction in the serological test for syphilis in the modern era. International Immunopharmacology. 2014;20(2):331-336
  50. 50. Bopage RI, Vollmer-Conna U, Shand AW, Post JJ. Sex differences in the significance of isolated reactive treponemal chemiluminescence immunoassay results. Sexually Transmitted Infections. 2018;94(3):187-191
  51. 51. Mc Gready R, Kang J, Watts I, Tyrosvoutis ME, Torchinsky MB, Htut AM, et al. Audit of antenatal screening for syphilis and HIV in migrant and refugee women on the Thai-Myanmar border: A descriptive study. F1000Res. 2014;3:123
  52. 52. Katz AR, Komeya AY, Tomas JE. False-negative syphilis treponemal enzyme immunoassay results in an HIV-infected case-patient. International Journal of STD & AIDS. 2017;28(7):735-737
  53. 53. Mmeje O, Chow JM, Davidson L, Shieh J, Schapiro JM, Park IU. Discordant syphilis immunoassays in pregnancy: Perinatal outcomes and implications for clinical management. Clinical Infectious Diseases. 2015;61(7):1049-1053
  54. 54. Sönmez C, Demir T, Sezen F, Kılıç S. Investigation of syphilis coinfection and performance of the Architect syphilis Tp ELISA screening test in HIV positive patients. Turkey Journal of Medical Science. 2018;48(6):1129-1134. DOI: 10.3906/sag-1802-16
  55. 55. Motlagh MN, Javid CG. Presentation of ocular syphilis in a HIV-positive patient with false-negative serologic screening. Case Report of Infectious Diseases. 2019;2019:8191724
  56. 56. Bristow CC, Kojima N, Lee SJ, Leon SR, Ramos LB, Konda KA, et al. HIV and syphilis testing preferences among men who have sex with men and among transgender women in Lima, Peru. PLoS One. 2018;13(10):e0206204
  57. 57. Kalou MB, Castro A, Watson A, Jost H, Clay S, Tun Y, et al. Laboratory evaluation of the Chembio dual path platform HIV-syphilis assay. African Journal of Laboratory Medicine. 2016;5(1):433
  58. 58. Shakya G, Singh DR, Ojha HC, Ojha CR, Mishra SK, Malla K, et al. Evaluation of SD Bioline HIV/syphilis duo rapid test kits in Nepal. BMC Infectious Diseases. 2016;16(1):450. DOI: 10.1186/s12879-016-1694-9
  59. 59. Grégoire Y, Germain M, Delage G. Factors associated with a second deferral among donors eligible for re-entry after a false-positive screening test for syphilis, HCV, HBV and HIV. Vox Sang. 2018;113(4):339-344
  60. 60. Zhu WF, Lei SY, Li LJ. Hepatitis C virus infection and biological false-positive syphilis test: A single-center experience. Hepatobiliary & Pancreatic Diseases International. 2011;10(4):399-402. DOI: 10.1016/s1499-3872(11)60067-2
  61. 61. Benzaken AS, Bazzo ML, Galban E, Pinto IC, Nogueira CL, Golfetto L, et al. External quality assurance with dried tube specimens (DTS) for point-of-care syphilis and HIV tests: Experience in an indigenous populations screening programme in the Brazilian Amazon. Sexually Transmitted Infections. 2014;90(1):14-18
  62. 62. Sandes VS, Silva SGC, Motta IJF, Velarde LGC, de Castilho SR. Evaluation of positive and false-positive results in syphilis screening of blood donors in Rio de Janeiro, Brazil. Transfusion Medicine. 2017;27(3):200-206
  63. 63. Sachdev S, Sharma AK, Sethi S, Garg S, Lamba DS, Sharma RR, et al. Comparative evaluation of enzyme-linked immunosorbent assay with rapid plasma reagin for screening of syphilis in blood donors. Asian Journal of Transfusiion Science. 2018;12(2):165-168. DOI: 10.4103/ajts.AJTS_126_17
  64. 64. Theodoropoulos N, Jaramillo A, Penugonda S, Wasik C, Brooks K, Ladner DP, et al. Improving syphilis screening in deceased organ donors. Transplantation. 2015;99(2):438-443. DOI: 10.1097/TP.0000000000000323
  65. 65. Naesens R, Vermeiren S, Van Schaeren J, Jeurissen A. False positive Lyme serology due to syphilis: Report of 6 cases and review of the literature. Acta Clinica Belgica. 2011;66(1):58-59
  66. 66. Toumanios C, Prisco L, Dattwyler RJ, Arnaboldi PM. Linear B cell epitopes derived from the multifunctional surface lipoprotein BBK32 as targets for the serodiagnosis of lyme disease. mSphere. 2019;4:3
  67. 67. Park IU, Chow JM, Bolan G, Stanley M, Shieh J, Schapiro JM. Screening for syphilis with the treponemal immunoassay: Analysis of discordant serology results and implications for clinical management. The Journal of Infectious Diseases. 2011;204(9):1297-1304
  68. 68. Hoover KW, Radolf JD. Serodiagnosis of syphilis in the recombinant era: Reversal of fortune. The Journal of Infectious Diseases. 2011;204(9):1295-1296
  69. 69. Dassah ET, Adu-Sarkodie Y, Mayaud P. Performance of syphilis sentinel surveillance in the context of endemic treponematoses: experience from Ghana. BMC Infectious Diseases. 2016;16(1):745
  70. 70. Gu WM, Yang Y, Wang QZ, Pan BS, Guo W, Wu L, et al. Comparing the performance of traditional non-treponemal tests on syphilis and non-syphilis serum samples. International Journal of STD & AIDS. 2013;24(12):919-925
  71. 71. Nah EH, Cho S, Kim S, Cho HI, Chai JY. Comparison of traditional and reverse syphilis screening algorithms in medical health Checkups. Annals of Laboratory Medicine. 2017;37(6):511-515. DOI: 10.3343/alm.2017.37.6.511
  72. 72. Rourk AR, Litwin CM. Evaluation of the BioPlex 2200 syphilis total screen (IgG/IgM) with reflex to an automated rapid plasma reagin test. Journal of Clinical Laboratory Analysis. 2019;33(5):e22878
  73. 73. Yen-Lieberman B, Daniel J, Means C, Waletzky J, Daly TM. Identification of false-positive syphilis antibody results using a semiquantitative algorithm. Clinical and Vaccine Immunology. 2011;18(6):1038-1040
  74. 74. Zhou J, Liang Y, Zhang J, Cui L. The analyzation and clinical evaluation of ECLIA and CMIA in the detection of Treponema pallidum. Medicine (Baltimore). 2017;96(24):e7139. DOI: 10.1097/MD.0000000000007139
  75. 75. Shen X, Liu D, Lin Y, Zhu XZ, Lin LR, Tong ML, et al. The characteristics of beta 2-glycoprotein I-dependent anticardiolipin antibody and blood coagulation status in subjects with classical biological false-positive syphilis reactions. International Immunopharmacology. 2018;62:132-138
  76. 76. Wang Q , Lei Y, Lu X, Wang G, Du Q , Guo X, et al. Urea-mediated dissociation alleviate the false-positive Treponema pallidum-specific antibodies detected by ELISA. PLoS One. 2019;14(3):e0212893
  77. 77. Leamer NK, Jordan NN, Pacha LA, Latif NH, Garges EC, Gaydos JC. Survey of sexually transmitted disease laboratory methods in U.S. Army Laboratories, 2012. Military Medicine. 2017;182(3):e1726-e1732. DOI: 10.7205/MILMED-D-16-00248
  78. 78. Li Z, Feng Z, Liu P, Yan C. Screening for antibodies against Treponema pallidum with chemiluminescent microparticle immunoassay: Analysis of discordant serology results and clinical characterization. Annals of Clinical Biochemistry. 2016;53(Pt 5):588-592
  79. 79. Adhikari EH, Frame IJ, Hill E, Fatabhoy R, Strickland AL, Cavuoti D, et al. Abbott ARCHITECT syphilis TP chemiluminescent immunoassay accurately diagnoses past or current syphilis in pregnancy. American Journal of Perinatology. 2020;37(1):112-118
  80. 80. Tao C, Hao X, Xu W, Zhang J, Pan S, Tao Z, et al. Evaluation of the Elecsys syphilis immunoassay for routine screening of serum samples in China. Scientific Reports. 2017;7(1):9559
  81. 81. Li D, An J, Wang T, Tao C, Wang L. Clinical evaluation of fully automated Elecsys® syphilis assay for the detection of antibodies of Treponema pallidum. Journal of Clinical Laboratory Analysis. 2016;30(6):1164-1168
  82. 82. Enders M, Hunjet A, Gleich M, Imdahl R, Mühlbacher A, Schennach H, et al. Performance evaluation of the Elecsys syphilis assay for the detection of total antibodies to Treponema pallidum. Clinical and Vaccine Immunology. 2015 Jan;22(1):17-26
  83. 83. Simčič S, Potočnik M. Serological diagnosis of syphilis: A comparison of different diagnostic methods. Acta Dermatovenerol Alp Pannonica Adriat. 2015;24(2):17-20
  84. 84. Song X, Tian L, Zou H, Sun H. Analysis of the clinical diagnosis data of four experimental detection methods for pediatric syphilis. Minerva Pediatric. 2019;71(2):144-149
  85. 85. Nutten S. Atopic dermatitis: Global epidemiology and risk factors. Annals of Nutrition & Metabolism. 2015;66(Suppl. 1):8-16
  86. 86. Silverberg JI. Public health burden and epidemiology of atopic dermatitis. Dermatologic Clinics. 2017;35(3):283-289
  87. 87. Khamaganova IV, Novozhilova OL, Vorontsova IV. Epidemiology of atopic dermatitis. The Russian Journal of Dermatology and Venereology. 2017;16(4):21-25
  88. 88. Sacotte R, Silverberg JI. Epidemiology of adult atopic dermatitis. Clinical Dermatology. 2018;36(5):595-605
  89. 89. Raciborski F, Jahnz-Rozyk K, Kłak A, Sybilski AJ, Grąbczewska AM, Brzozowska M, et al. Epidemiology and direct costs of atopic dermatitis in Poland based on the National Health Fund register (2008-2017). Postepy Dermatology and Alergology. 2019;36(6):727-733
  90. 90. Sendrasoa FA, Ranaivo IM, Razanakoto NH, Andrianarison M, Raharolahy O, Ratovonjanahary VT, et al. Epidemiology and associated factors of atopic dermatitis in Malagasy children. Allergy, Asthma and Clinical Immunology. 2020;16:4
  91. 91. Halling AS, Bager P, Skov L, Zachariae C, Wohlfahrt J, Melbye M, et al. The interaction between filaggrin mutations and hard domestic water on the risk of early-onset atopic dermatitis. The British Journal of Dermatology. 2020;183(2):406-407
  92. 92. Ražnatović Đurović M, Janković J, Ćirković A, Sojević Timotijević Z, Rašić J, Vitković L, et al. Impact of atopic dermatitis on the quality of life of children and their families. Italian Dermatology Venereology. 2020;156(1):29-35

Written By

Nikolay Potekaev, Olga Zhukova and Irina Khamaganova

Submitted: 19 June 2022 Reviewed: 07 July 2022 Published: 24 August 2022